Breaking News
March 23, 2019 - Study suggests depression screening when assessing African-Americans for schizophrenia
March 23, 2019 - New electronic support system for choosing drug treatment based on patient’s genotype
March 23, 2019 - First-of-its-kind study provides pregnancy statistics of imprisoned U.S. women
March 23, 2019 - Marinus Pharmaceuticals Initiates Phase 3 Study in Children with PCDH19-Related Epilepsy
March 23, 2019 - Laparoscopy: MedlinePlus Lab Test Information
March 23, 2019 - Shellfish allergies: can they be treated?
March 23, 2019 - Toilet seat heart monitoring system
March 23, 2019 - Researchers identify way to improve common treatment for PTSD
March 23, 2019 - High potency cannabis use linked to psychosis finds study
March 23, 2019 - Evoke Pharma Submits Response to FDA Review Letter for Gimoti NDA
March 23, 2019 - Tracking HIV’s ever-evolving genome in effort to prioritize public health resources
March 23, 2019 - Scientists grow most sophisticated brain organoid to date
March 23, 2019 - ADHD drug raising risk of psychosis
March 22, 2019 - FDA approves brexanolone, first drug developed to treat postpartum depression
March 22, 2019 - Gruesome cat and dog experiments by the USDA exposed
March 22, 2019 - Ball pits used in children’s physical therapy may contribute to germ transmission
March 22, 2019 - Long-term use of inexpensive weight-loss drug may be safe and effective
March 22, 2019 - FDA Approves Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
March 22, 2019 - Anti-Müllerian Hormone Test: MedlinePlus Lab Test Information
March 22, 2019 - Finding the right exercise, diet aids for HIV patients
March 22, 2019 - Health Plans For State Employees Use Medicare’s Hammer On Hospital Bills
March 22, 2019 - Researchers develop new tool for imaging large groups of neurons in living animals
March 22, 2019 - Certain bacteria and immune factors in vagina may cause or protect against preterm birth
March 22, 2019 - Novel breath test could pave new way to non-invasively measure gut health
March 22, 2019 - Pharmaceutical and personal care products may result in new contaminants in waterways
March 22, 2019 - ACC: Catheter Ablation Does Not Cut Mortality, Stroke in A-Fib
March 22, 2019 - Wiedemann-Rautenstrauch syndrome – Genetics Home Reference
March 22, 2019 - Health insurance is not assurance of healthcare
March 22, 2019 - Supporting “curiosity-driven research” at the Discovery Innovation Awards
March 22, 2019 - Must-Reads Of The Week (Some Flying Below The Radar)
March 22, 2019 - Newly engineered nanoscale protein micelles can be tracked by MRI
March 22, 2019 - Mayo Clinic study identifies potential new drug therapy for liver diseases
March 22, 2019 - Pitt engineers win $550,000 NSF CAREER award to develop new intervention for people with ASD
March 22, 2019 - Early discharge does not increase readmission risk for patients after lung surgery
March 22, 2019 - Creating diverse pool of trained scientists to address Alzheimer’s research needs
March 22, 2019 - Surprising discovery offers clues to limit graft-vs.-host disease
March 22, 2019 - Study shows ACA’s positive impact on healthcare affordability and access for women
March 22, 2019 - Study provides new pathway for controlling inflammation
March 22, 2019 - New combination treatment shows promise for common brain tumor in children
March 22, 2019 - Virginia Tech Helmet Lab releases first youth-specific football helmet ratings
March 22, 2019 - New algae-based treatment could reduce need for limb amputation
March 22, 2019 - Stroke risk reduces in both black and white older Medicare beneficiaries, study reports
March 22, 2019 - City of Hope exhibits current studies and data on cancer therapies at AACR
March 22, 2019 - New study identifies CD40 molecule as key entry point for dangerous bacteria
March 22, 2019 - Health Tip: Six Steps to a Healthier Life
March 22, 2019 - even a little activity helps you live longer
March 22, 2019 - Many individuals recovering from addiction continue to suffer from chronic physical disease
March 22, 2019 - New drugs on PBS for Parkinson’s, MND and Cutaneous T cell lymphoma
March 22, 2019 - Saving energy also saves lives, UW-Madison study says
March 22, 2019 - Former inmates who receive social support have better mental health, study finds
March 22, 2019 - Nanofibrous membrane could enhance periodontal tissue regeneration
March 22, 2019 - Anti-vaxxer Italian leader down with chickenpox
March 22, 2019 - Servier collaborates with Harvard researchers to fight metabolic diseases
March 22, 2019 - National Eating Disorders Association
March 22, 2019 - Pumping up red blood cell production
March 22, 2019 - Excessive phosphate fertilizer may hurt plants by altering microbial composition in soil
March 22, 2019 - Medical marijuana laws could be improving older Americans’ health, study suggests
March 22, 2019 - Study indicates the benefits of stopping aspirin in heart attack patients
March 22, 2019 - Deep brain stimulation offers significant relief for patients with treatment-resistant depression
March 22, 2019 - Mental health problems in young adults on the rise
March 22, 2019 - Innovative membrane offers a viable solution for periodontitis
March 22, 2019 - The FDA Grants Rare Pediatric Disease Designation to Odiparcil for the Treatment of MPS VI
March 22, 2019 - insulin therapy: MedlinePlus Medical Encyclopedia
March 22, 2019 - Guidelines on the use of genetic testing in psychiatry
March 22, 2019 - Aspiring Doctors Seek Advanced Training In Addiction Medicine
March 22, 2019 - A change in focus could enable the development of new treatments for Alzheimer’s disease
March 22, 2019 - A new way to visualize the immune cell “landscape” of bowel cancer tumors
March 22, 2019 - Understanding maintenance of quiescent stem cells in chronic myelogenous leukemia
March 22, 2019 - Ludwig scientists to share advances in cancer research at AACR Annual Meeting 2019
March 22, 2019 - Less invasive valve replacement can be safe and effective alternative for healthier patients
March 22, 2019 - Aphasia research reveals new, complex interactions between thought and language
March 22, 2019 - Artificial neural networks can predict how different areas in the brain respond to words
March 22, 2019 - Age-related changes to gut microbiome have adverse impact on vascular health, study shows
March 22, 2019 - Study provides new insight into blood cell and immune cell production
March 22, 2019 - Isolated seniors chat online to prevent cognitive decline
March 22, 2019 - Repurposing drugs to outsmart cancers
March 22, 2019 - Naltrexone implant more effective in reducing relapses in HIV patients with opioid addiction
March 22, 2019 - The Brain Institute wins $7.04 million grant to investigate ‘neurophilosphy of free will’
March 22, 2019 - Karyopharm Announces FDA Extension of Review Period for Selinexor New Drug Application
March 22, 2019 - Eruptive xanthomatosis
Snail’s eye inspires new type of RIOCATH urinary catheter

Snail’s eye inspires new type of RIOCATH urinary catheter

image_pdfDownload PDFimage_print

The Czech company Riocath Global developed and patented in collaboration with the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB Prague) a world-wide unique technology applicable to tubular medical devices. One of the first clinically significant applications is a new form of urinary catheter. The RIOCATH® (Reversal Inside-Out CATHeterisation) design greatly reduces the risk of introducing infection into the body as well as the trauma of sensitive tissues. So far, private investors have invested more than two million euros in the development. Clinical trials will begin by the end of this year and the first product market entry is expected in 2019.

Every day, various types of catheters, probes, tracheal tubes and drains are used by millions of patients around the world, protecting their health and in many cases saving their lives. However, application of tubular devices is also associated with certain risks, such as infection, as well as with considerable discomfort and pain for the patient. Insertion in the human body and use of such device often results in irritation or even damage to soft tissues or mucous membranes and subsequent scarring of the tissue. Another danger resulting from the use of current catheters is the introduction of infection into the patient’s body that cannot be fully prevented even if the best sterilization techniques are used. The reason is that as the catheter makes its way through the urethra into the bladder it carries on its surface the microbes from the urethra’s tip. Infection then easily spreads into the kidneys and can even be carried by blood to other parts of the body.

“Application of double-skinned RIOCATH® catheters will revolutionize patient care in many health care fields. The unique patented mechanism can significantly reduce the risk of infection and damage to tissues in comparison to existing medical devices and makes for a safer and more comfortable use. Unlike old catheters whose casing rubs on the urethra’s wall during its insertion, the new technology allows for the catheter to extend by unfolding itself from the inside out, virtually imitating a snail’s eye stalk,” explains Miroslav Svoboda, MD, the project initiator, co-inventor and CEO of Riocath Global.

The new type of RIOCATH® urinary catheter will be of great benefit to a broad spectrum of patients. A significant reduction in the number of infections, mainly of the urinary tract, should contribute significantly to reducing the need for antibiotic treatment. All this will lead to a better, more comfortable patient care and to significant savings in the health care system.

The Riocath Global team has been cooperating with the IOCB Prague and its Development Center since the beginning of the project in 2013. “Dr. Svoboda came up with a revolutionary technical solution and was searching for an institution capable of assisting with the development of a functional prototype,” says Prof. Martin Fusek, IOCB Prague Deputy Director. “Although this is not a typical field for the IOCB Prague, our Development Center could provide expertise and was able to help him. We’re very pleased that the Institute can assist with such a remarkable invention that has the potential to protect hundreds of thousands of patients from unnecessary infections and other health complications.”

The RIOCATH® project has raised more than two million euros from private investors. “Upon completion of clinical trials and marketing of the catheter, the estimated value of the company will grow to tens of millions of euros. Apart from urinary catheters, the principle can be used in a number of other applications which are part of the company’s development portfolio, in most cases with considerable market and therapeutic potential,” commented on the importance of the patented technology Jaromír Zahrádka, Ph.D., a member of the Board of directors of Riocath Global responsible for the intellectual property protection, and the CEO of the i&i Prague, a biotech incubator founded at IOCB Prague. “RIOCATH®‘s technical solution is a unique one worldwide as was confirmed by a comprehensive search by the European Patent Office after the application was first filed. So RIOCATH®‘s principle and use will most likely have adequate patent protection throughout the world,” concluded Jaromír Zahrádka.

During the development of the new type of catheter, a wide range of concepts had been designed and tested at the IOCB Development Center before the final prototype was created. “When you pull back an ordinary latex or silicone tube to make a double layer, you can’t pull the outer layer on for more than a few centimeters because of clamping forces and friction. RIOCATH® is unique because of the catheter’s dynamic character which allows for the layers to move smoothly on one another when the catheter’s tip extends,” explains co-author of the invention Ing. Vít Pokorný from IOCB Development Center. “Thanks to the excellent collaboration with the Centre of Polymer Systems at Tomas Bata University in Zlín and the contribution of Compuplast and several other partners, we were able to create several concepts of the catheter prototype with different forms of active profile and to choose the optimal solution for the urinary catheter,” adds Vít Pokorný.

The RIOCATH® solution was already presented to the Czech Society of Hospital Epidemiology and Hygiene and impressed its experts. “The RIOCATH® mechanism has a potential to significantly reduce the incidence of catheterization-related infections in hospitals. If clinical tests demonstrate the properties of these products, as shown by preclinical tests so far, this will be undoubtedly a revolutionary step in catheterization. It will enable health professionals to make catheterization more patient-friendly and to more effectively prevent the risk of infections. The potential extension of RIOCATH® technology will be of benefit to patients,” expressed the opinion of hospital hygienists and epidemiologists Pavel Totušek, MD, Chairman of the Czech Society of Epidemiology and Hygiene.

Tagged with:

About author

Related Articles